MRNA logo

Moderna (MRNA) Shareholders Equity

Annual Shareholders Equity

$13.85 B
-$5.27 B-27.55%

31 December 2023

MRNA Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$11.93 B
+$215.00 M+1.84%

30 September 2024

MRNA Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MRNA Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-27.6%-11.4%
3 y3 years+441.0%+17.8%
5 y5 years+805.4%+852.8%

MRNA Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-27.6%+441.0%-37.6%+17.8%
5 y5 years-27.6%+1079.3%-37.6%+915.2%
alltimeall time-27.6%>+9999.0%-37.6%>+9999.0%

Moderna Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$11.93 B(+1.8%)
June 2024
-
$11.71 B(-8.6%)
Mar 2024
-
$12.82 B(-7.5%)
Dec 2023
$13.85 B(-27.6%)
$13.85 B(+3.0%)
Sept 2023
-
$13.46 B(-20.6%)
June 2023
-
$16.95 B(-10.1%)
Mar 2023
-
$18.86 B(-1.4%)
Dec 2022
$19.12 B(+35.2%)
$19.12 B(+6.3%)
Sept 2022
-
$17.99 B(+0.0%)
June 2022
-
$17.98 B(+5.3%)
Mar 2022
-
$17.07 B(+20.7%)
Dec 2021
$14.14 B(+452.3%)
$14.14 B(+39.7%)
Sept 2021
-
$10.12 B(+51.0%)
June 2021
-
$6.70 B(+74.7%)
Mar 2021
-
$3.84 B(+49.9%)
Dec 2020
$2.56 B(+118.0%)
$2.56 B(-7.2%)
Sept 2020
-
$2.76 B(-6.3%)
June 2020
-
$2.95 B(+79.6%)
Mar 2020
-
$1.64 B(+39.7%)
Dec 2019
$1.17 B(-23.2%)
$1.17 B(-6.2%)
Sept 2019
-
$1.25 B(-6.5%)
June 2019
-
$1.34 B(-7.4%)
Mar 2019
-
$1.45 B(-5.5%)
Dec 2018
$1.53 B(+144.7%)
$1.53 B(+42.2%)
Sept 2018
-
$1.08 B(+8773.8%)
June 2018
-
$12.13 M(-1627.8%)
Mar 2018
-
-$794.00 K(-100.1%)
Dec 2017
$625.30 M(-25.7%)
$625.30 M(>+9900.0%)
Sept 2017
-
$1.63 M(-34.1%)
June 2017
-
$2.47 M(-27.6%)
Mar 2017
-
$3.42 M(+6.2%)
Dec 2016
$841.85 M(>+9900.0%)
-
Dec 2016
-
$3.22 M(+129.4%)
Sept 2016
-
$1.40 M(+30.5%)
June 2016
-
$1.07 M(-27.7%)
Mar 2016
-
$1.49 M(+465.0%)
Dec 2015
$263.00 K(-106.0%)
$263.00 K(-165.8%)
Sept 2015
-
-$400.00 K(-84.0%)
June 2015
-
-$2.50 M(-31.7%)
Mar 2015
-
-$3.65 M(-16.5%)
Dec 2014
-$4.37 M(-38.1%)
-$4.37 M(-57.1%)
Sept 2014
-
-$10.19 M(+206.1%)
June 2014
-
-$3.33 M(-54.4%)
Mar 2014
-
-$7.30 M(+3.3%)
Dec 2013
-$7.06 M(+25.5%)
-$7.06 M(+37.4%)
Sept 2013
-
-$5.14 M(+22.4%)
June 2013
-
-$4.20 M(-0.5%)
Mar 2013
-
-$4.22 M(-25.0%)
Dec 2012
-$5.63 M(<-9900.0%)
-$5.63 M(+139.5%)
Sept 2012
-
-$2.35 M(+27.0%)
June 2012
-
-$1.85 M(-44.5%)
Mar 2012
-
-$3.34 M(-8881.6%)
Dec 2011
$38.00 K(-99.8%)
$38.00 K(-99.8%)
Sept 2011
-
$15.88 M(-2.7%)
June 2011
-
$16.32 M(-15.4%)
Mar 2011
-
$19.28 M(+12.3%)
Dec 2010
$17.17 M(-349.3%)
$17.17 M(-349.3%)
Sept 2010
-
-$6.89 M(-47.8%)
June 2010
-
-$13.20 M(+38.6%)
Mar 2010
-
-$9.52 M(+38.3%)
Dec 2009
-$6.89 M
-$6.89 M(+3.8%)
Sept 2009
-
-$6.64 M(+596.4%)
June 2009
-
-$953.00 K(-123.2%)
DateAnnualQuarterly
Mar 2009
-
$4.11 M(-226.2%)
Dec 2008
-$3.26 M(-108.3%)
-$3.26 M(-161.2%)
Sept 2008
-
$5.32 M(-71.1%)
June 2008
-
$18.45 M(-23.5%)
Mar 2008
-
$24.12 M(-38.5%)
Dec 2007
$39.22 M(-9.5%)
$39.22 M(-21.2%)
Sept 2007
-
$49.74 M(-21.5%)
June 2007
-
$63.40 M(-14.8%)
Mar 2007
-
$74.38 M(+71.6%)
Dec 2006
$43.34 M(-22.0%)
$43.34 M(-15.9%)
Sept 2006
-
$51.51 M(-11.0%)
June 2006
-
$57.86 M(+2.5%)
Mar 2006
-
$56.44 M(+1.6%)
Dec 2005
$55.57 M(-4.4%)
$55.57 M(-12.0%)
Sept 2005
-
$63.17 M(+38.4%)
June 2005
-
$45.66 M(-12.9%)
Mar 2005
-
$52.42 M(-9.8%)
Dec 2004
$58.15 M(+224.7%)
$58.15 M(+510.5%)
Sept 2004
-
$9.52 M(-42.3%)
June 2004
-
$16.50 M(+51.1%)
Mar 2004
-
$10.92 M(-39.0%)
Dec 2003
$17.91 M(+107.1%)
$17.91 M(-23.7%)
Sept 2003
-
$23.47 M(+20.8%)
June 2003
-
$19.43 M(+231.8%)
Mar 2003
-
$5.86 M(-32.3%)
Dec 2002
$8.64 M(-35.9%)
$8.64 M(-36.8%)
Sept 2002
-
$13.69 M(-18.0%)
June 2002
-
$16.69 M(-1.8%)
Mar 2002
-
$17.00 M(+26.0%)
Dec 2001
$13.49 M(+41.1%)
$13.49 M(+40.2%)
Sept 2001
-
$9.63 M(-5.3%)
June 2001
-
$10.16 M(-11.1%)
Mar 2001
-
$11.43 M(+19.5%)
Dec 2000
$9.56 M(-42.4%)
$9.56 M(-11.7%)
Sept 2000
-
$10.83 M(-11.2%)
June 2000
-
$12.19 M(-15.6%)
Mar 2000
-
$14.45 M(-12.9%)
Dec 1999
$16.60 M(-34.9%)
$16.60 M(-14.9%)
Sept 1999
-
$19.50 M(-11.0%)
June 1999
-
$21.90 M(-6.0%)
Mar 1999
-
$23.30 M(-8.6%)
Dec 1998
$25.50 M(+2.4%)
$25.50 M(-4.5%)
Sept 1998
-
$26.70 M(-0.7%)
June 1998
-
$26.90 M(+6.3%)
Mar 1998
-
$25.30 M(+1.6%)
Dec 1997
$24.90 M(+111.0%)
$24.90 M(-6.7%)
Sept 1997
-
$26.70 M(-4.6%)
June 1997
-
$28.00 M(-3.1%)
Mar 1997
-
$28.90 M(+265.8%)
Dec 1996
$11.80 M(+55.3%)
-
Sept 1996
-
$7.90 M(+3.9%)
June 1996
$7.60 M(0.0%)
$7.60 M(+76.7%)
Mar 1996
-
$4.30 M(+4.9%)
Dec 1995
-
$4.10 M(-4.7%)
Sept 1995
-
$4.30 M(-43.4%)
June 1995
$7.60 M(+76.7%)
$7.60 M(+72.7%)
Mar 1995
-
$4.40 M(0.0%)
Dec 1994
-
$4.40 M(0.0%)
Sept 1994
-
$4.40 M(+2.3%)
June 1994
$4.30 M
$4.30 M(+2.4%)
Mar 1994
-
$4.20 M(0.0%)
Dec 1993
-
$4.20 M(-940.0%)
Sept 1993
-
-$500.00 K

FAQ

  • What is Moderna annual stockholders equity?
  • What is the all time high annual shareholders equity for Moderna?
  • What is Moderna annual shareholders equity year-on-year change?
  • What is Moderna quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Moderna?
  • What is Moderna quarterly shareholders equity year-on-year change?

What is Moderna annual stockholders equity?

The current annual shareholders equity of MRNA is $13.85 B

What is the all time high annual shareholders equity for Moderna?

Moderna all-time high annual stockholders equity is $19.12 B

What is Moderna annual shareholders equity year-on-year change?

Over the past year, MRNA annual stockholders equity has changed by -$5.27 B (-27.55%)

What is Moderna quarterly stockholders equity?

The current quarterly shareholders equity of MRNA is $11.93 B

What is the all time high quarterly shareholders equity for Moderna?

Moderna all-time high quarterly stockholders equity is $19.12 B

What is Moderna quarterly shareholders equity year-on-year change?

Over the past year, MRNA quarterly stockholders equity has changed by -$1.53 B (-11.36%)